1. Home
  2. MDXH vs AFJK Comparison

MDXH vs AFJK Comparison

Compare MDXH & AFJK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • AFJK
  • Stock Information
  • Founded
  • MDXH 2003
  • AFJK 2023
  • Country
  • MDXH Belgium
  • AFJK United States
  • Employees
  • MDXH N/A
  • AFJK N/A
  • Industry
  • MDXH
  • AFJK
  • Sector
  • MDXH
  • AFJK
  • Exchange
  • MDXH Nasdaq
  • AFJK NYSE
  • Market Cap
  • MDXH 93.1M
  • AFJK 96.8M
  • IPO Year
  • MDXH 2021
  • AFJK 2023
  • Fundamental
  • Price
  • MDXH $1.96
  • AFJK $10.75
  • Analyst Decision
  • MDXH Strong Buy
  • AFJK
  • Analyst Count
  • MDXH 2
  • AFJK 0
  • Target Price
  • MDXH $7.00
  • AFJK N/A
  • AVG Volume (30 Days)
  • MDXH 145.0K
  • AFJK 59.0K
  • Earning Date
  • MDXH 02-26-2025
  • AFJK 01-01-0001
  • Dividend Yield
  • MDXH N/A
  • AFJK N/A
  • EPS Growth
  • MDXH N/A
  • AFJK N/A
  • EPS
  • MDXH N/A
  • AFJK 0.29
  • Revenue
  • MDXH $84,708,000.00
  • AFJK N/A
  • Revenue This Year
  • MDXH $27.57
  • AFJK N/A
  • Revenue Next Year
  • MDXH $20.09
  • AFJK N/A
  • P/E Ratio
  • MDXH N/A
  • AFJK $36.60
  • Revenue Growth
  • MDXH 33.01
  • AFJK N/A
  • 52 Week Low
  • MDXH $1.55
  • AFJK $10.80
  • 52 Week High
  • MDXH $4.44
  • AFJK $10.85
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 38.10
  • AFJK N/A
  • Support Level
  • MDXH $1.97
  • AFJK N/A
  • Resistance Level
  • MDXH $2.25
  • AFJK N/A
  • Average True Range (ATR)
  • MDXH 0.16
  • AFJK 0.00
  • MACD
  • MDXH -0.04
  • AFJK 0.00
  • Stochastic Oscillator
  • MDXH 0.00
  • AFJK 0.00

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About AFJK AIMEI HEALTH TECHNOLOGY CO LTD

Aimei Health Technology Co Ltd is a blank check company.

Share on Social Networks: